- Citations, last 5 years
- 139
- Works, last 5 years
- 72
- h-index
- 40
- Scientists listed
- 12
- Grants since 2016
- 829
Grants received
2023–2027 · research · R01
Regulation of Blood Glycoproteins by Lectin Receptors in Health and Disease
Jamey Marth · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
Lukas Chavez · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R50
Development and Implementation of Advanced Technologies for Cancer Metabolism Research
David Anderson Scott · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.
Debanjan Dhar · Discovery Institute · funded by National Institutes of Health
2023–2026 · cooperative agreement · U01
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
Robert M Anthenelli · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases
Debanjan Dhar · Discovery Institute · funded by National Institutes of Health
2023–2025 · research · R56
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
Bradley T. Hyman · Discovery Institute · funded by National Institutes of Health
2023–2024 · research · R37
Regulation of the tumor microenvironment by DNA damage repair proteins
Svasti Haricharan · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer
Cosimo Commisso · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
Douglas J Sheffler · Discovery Institute · funded by National Institutes of Health
2023–2024 · research · R21
Transcriptional activation of LAMC1 as a resistance mechanism in recurrent PFA Ependymoma
Lukas Chavez · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Improving Proinsulin Folding to Ameliorate Type II Diabetes
Peter Arvan · Discovery Institute · funded by National Institutes of Health
2023–2024 · research · R21
Testing the utility of miBioAge as a personalized aging biomarker
Alexey V Terskikh · Discovery Institute · funded by National Institutes of Health
2023 · research · R21
Disruption of a DNA loop as a complementary mechanism of H3.3K27M mutations
Lukas Chavez · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
Lukas Chavez · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Improving Proinsulin Folding to Ameliorate Type II Diabetes
Peter Arvan · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Novel Neuroprotective Roles for the Alzheimer's Disease Risk Gene SORLA in Tau Pathology and Pathogenesis
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2023–2026 · cooperative agreement · U01
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
Robert M Anthenelli · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Novel Neuroprotective Roles for the Alzheimer's Disease Risk Gene SORLA in Tau Pathology and Pathogenesis
Timothy Yikai Huang · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Investigation of ecDNA as a driver of intratumoral heterogeneity and treatment resistance in high-risk medulloblastoma
Lukas Chavez · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R37
NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
Michael Karin · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R50
Development and Implementation of Advanced Technologies for Cancer Metabolism Research
David Anderson Scott · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Dissecting the Intracellular and Extracellular Role of TREM2 in the Pathogenesis of Non-Alcoholic Steatohepatitis.
Debanjan Dhar · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
Michael Karin · Discovery Institute · funded by National Institutes of Health
2023–2026 · cooperative agreement · U01
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
Nicholas David Cosford · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases
Debanjan Dhar · Discovery Institute · funded by National Institutes of Health
2023–2028 · research · R01
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
Douglas J Sheffler · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Improving Proinsulin Folding to Ameliorate Type II Diabetes
Peter Arvan · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer
Cosimo Commisso · Discovery Institute · funded by National Institutes of Health
2023–2027 · research · R01
Regulation of Blood Glycoproteins by Lectin Receptors in Health and Disease
Jamey Marth · Discovery Institute · funded by National Institutes of Health
2022–2024 · research · R21
Exploratory Therapy for the Skeletal/Dental Phenotype in PHOSPHO1 Deficiency
Jose Luis Millan · Discovery Institute · funded by National Institutes of Health
2022–2026 · research · R01
Microglial heparan sulfate in the modulation of APOE function and neurodegeneration
Yu Yamaguchi · Discovery Institute · funded by National Institutes of Health
2022–2024 · research · R21
Epigenetic drift of the Aging Heart in Drosophila
Maria Clara Guida · Discovery Institute · funded by National Institutes of Health
2022–2027 · research · R01
Molecular Pathogenesis of AF10-Rearranged Leukemias
Aniruddha J. Deshpande · Discovery Institute · funded by National Institutes of Health
2022–2026 · research · R01
Function and Mechanism of the Hippo-PI5P4K Axis for Growth Control
Brooke M Emerling · Discovery Institute · funded by National Institutes of Health
2022–2027 · research · R01
EPHA2 Receptor Signaling in Breast Cancer Mechanotransduction
Elena B Pasquale · Discovery Institute · funded by National Institutes of Health
2022–2024 · research · R21
Novel Strategy to Quantitate Delayed Aging by Caloric Restriction
Alexey V Terskikh · Discovery Institute · funded by National Institutes of Health
2022–2026 · research · R01
Function and Mechanism of the Hippo-PI5P4K Axis for Growth Control
Brooke M Emerling · Discovery Institute · funded by National Institutes of Health
2022–2027 · research · R01
Targeting ER+ Breast Cancer Through Induced Viral Mimicry
Charles H. Spruck · Discovery Institute · funded by National Institutes of Health
2022–2026 · research · R01
Comparative resistomics of Gram-negative bacterial pathogens
Andrei L Osterman · Discovery Institute · funded by National Institutes of Health